Market research

Resuscitation Devices Market

Explore licenses

Assess the study’s coverageRead the public overview, then compare the chapter outline with your research brief.

18report chapters

360iResearch introduction

Public research overview

Resuscitation Devices: Executive Summary

Resuscitation devices support the rapid recognition, stabilization, and treatment of patients experiencing cardiac arrest, respiratory failure, or other life-threatening emergencies. The market encompasses equipment used across hospitals, emergency medical services, ambulances, public-access settings, and other acute-care environments. Demand is shaped by emergency preparedness, clinical protocols, device interoperability, training capacity, procurement standards, and the availability of reliable service and maintenance.

Inside the research

Coverage at a glance

Selected branches from the published table of contents. Follow a chapter to see every subchapter in context.

  1. Chapter 7 Product Type

    • Airway Management Devices
    • Defibrillators
    • Oxygen Delivery Equipment
    • Suction Devices
    View chapter
  2. Chapter 8 Patient Type

    • Adult
    • Pediatric
    • Neonatal
    View chapter
  3. Chapter 9 Portability

    • Portable
    • Stationary
    • Wearable
    View chapter

Emergency-Care Priorities Are Reshaping Device Adoption

The landscape is shifting toward faster response, simplified workflows, and greater continuity between prehospital and hospital care. Public-access defibrillation programs, automated external defibrillator deployment, mechanical compression technologies, airway-management tools, monitoring systems, and integrated emergency carts are being evaluated not only for technical performance but also for usability, portability, durability, connectivity, and readiness. Procurement decisions increasingly emphasize total lifecycle value, clinician training, consumables management, cybersecurity, and the ability to standardize care across varied locations.

Artificial Intelligence Strengthens Triage, Guidance, and Quality Improvement

Artificial intelligence is contributing to resuscitation workflows through signal interpretation, event detection, decision support, predictive alerts, and post-event analysis. Its practical value depends on clinically validated algorithms, high-quality physiological data, transparent performance measures, and integration with established response protocols. AI can help prioritize alarms, guide users through time-critical steps, assess trends in patient data, and identify opportunities for training improvement, but implementation requires human oversight, privacy safeguards, interoperability controls, and clear accountability when recommendations influence care.

Regional Insights: Infrastructure and Preparedness Drive Variation

North America is characterized by advanced emergency-care infrastructure, mature EMS systems, and strong interest in connected monitoring and public-access response. Europe emphasizes coordinated clinical pathways, regulatory compliance, interoperability, and consistent quality across national health systems. Asia-Pacific combines advanced urban hospital capacity with significant variation in rural access, creating demand for portable, robust, and easy-to-use systems. Latin America is shaped by uneven EMS coverage, infrastructure constraints, and the need for dependable devices supported by training and service networks. The Middle East continues to prioritize emergency preparedness, hospital modernization, and mass-gathering response capabilities. Africa presents substantial opportunities to improve basic emergency access, maintenance capacity, workforce training, and deployment models suited to resource-constrained settings.

Group Insights: Standards and Cooperation Influence Procurement

ASEAN markets reflect diverse healthcare maturity, with opportunities linked to urbanization, hospital development, regional training, and adaptable procurement models. BRICS economies combine large and varied care systems with priorities around domestic capability, affordability, and broader emergency access. The European Union places strong emphasis on harmonized regulation, patient safety, cross-border compatibility, and coordinated health-system resilience. G7 members generally focus on advanced clinical performance, connected care, cybersecurity, and evidence-based deployment. GCC countries emphasize modern hospital infrastructure, emergency readiness, and workforce capability, including response to high-density events. NATO countries commonly prioritize interoperability, operational resilience, logistics, and emergency medical readiness across civilian and defense-related contexts.

Country Insights: Diverse Health Systems Require Tailored Deployment

Australia’s dispersed population increases the importance of portability, remote support, and coordinated retrieval care. Brazil’s large territory makes EMS coverage, regional service capacity, and affordability central considerations. Canada requires solutions suited to geographically dispersed communities and varied provincial systems. China is advancing hospital modernization and emergency-response capability across highly diverse settings. France, Germany, Italy, Spain, and the United Kingdom emphasize regulated clinical practice, organized EMS, training, and integration with established hospital pathways. India’s priorities include expanding emergency access, improving affordability, and supporting care across urban and rural environments. Japan and South Korea combine sophisticated healthcare infrastructure with strong interest in reliability, aging-population needs, and workflow efficiency. Mexico faces the need to strengthen prehospital coverage, training, and equipment maintenance. Russia’s requirements reflect geographic scale, infrastructure variation, and the importance of dependable supply and service arrangements. The United States continues to emphasize rapid response, public-access deployment, EMS integration, clinical evidence, and connected emergency-care workflows.

Action Priorities for Resuscitation-Device Leaders

Industry leaders should design around the complete response pathway rather than a single device category. Priorities include intuitive interfaces, rapid readiness checks, interoperable data exchange, robust battery and consumables management, and service models that support remote and resource-constrained locations. Organizations should segment offerings by care setting, strengthen simulation-based training, publish transparent clinical and usability evidence, and build cybersecurity and software-update governance into product planning. Partnerships with EMS providers, hospitals, public-health agencies, educators, and distributors can improve deployment quality, while local maintenance capability and responsible procurement practices can increase long-term reliability.

Research Methodology: Evidence-Led Market Assessment

This executive summary uses a structured assessment of resuscitation-device applications, care settings, technology functions, regulatory considerations, procurement requirements, and regional health-system conditions. Findings are synthesized from verifiable public information, including clinical guidance, regulatory materials, government and institutional publications, peer-reviewed research, and documented healthcare infrastructure indicators. The analysis distinguishes established evidence from emerging practice, avoids unsupported quantitative claims, and interprets regional, group, and country differences through access, preparedness, workflow, training, interoperability, and service considerations.

Conclusion: Reliable Systems Are Central to Better Resuscitation

Resuscitation devices are increasingly evaluated as components of coordinated emergency-response systems rather than isolated products. Progress will depend on combining dependable hardware with trained users, appropriate protocols, connected information flows, maintenance discipline, and equitable access. Leaders that align innovation with clinical evidence, usability, resilience, and local operating realities will be better positioned to support faster and more consistent emergency care across hospitals, EMS networks, public settings, and underserved communities.

Research report

Table of contents

  1. 1.Preface
    1. 1.1Objectives of the Study
    2. 1.2Market Definition
    3. 1.3Market Segmentation & Coverage
    4. 1.4Years Considered for the Study
    5. 1.5Currency Considered for the Study
    6. 1.6Language Considered for the Study
    7. 1.7Key Stakeholders
  2. 2.Research Methodology
    1. 2.1Introduction
    2. 2.2Research Design
      1. 2.2.1Primary Research
      2. 2.2.2Secondary Research
    3. 2.3Research Framework
      1. 2.3.1Qualitative Analysis
      2. 2.3.2Quantitative Analysis
    4. 2.4Market Size Estimation
      1. 2.4.1Top-Down Approach
      2. 2.4.2Bottom-Up Approach
    5. 2.5Data Triangulation
    6. 2.6Research Outcomes
    7. 2.7Research Assumptions
    8. 2.8Research Limitations
  3. 3.Executive Summary
    1. 3.1Introduction
    2. 3.2CXO Perspective
    3. 3.3New Revenue Opportunities
    4. 3.4Next-Generation Business Models
    5. 3.5Industry Roadmap
  4. 4.Market Overview
    1. 4.1Introduction
    2. 4.2Industry Ecosystem & Value Chain Analysis
      1. 4.2.1Supply-Side Analysis
      2. 4.2.2Demand-Side Analysis
      3. 4.2.3Stakeholder Analysis
    3. 4.3Market Dynamics
      1. 4.3.1Key Drivers
      2. 4.3.2Key Restraints
      3. 4.3.3Key Opportunities
      4. 4.3.4Key Challenges
    4. 4.4Porter’s Five Forces Analysis
    5. 4.5PESTLE Analysis
    6. 4.6Market Outlook
      1. 4.6.1Near-Term Market Outlook (0–2 Years)
      2. 4.6.2Medium-Term Market Outlook (3–5 Years)
      3. 4.6.3Long-Term Market Outlook (5–10 Years)
    7. 4.7Go-to-Market Strategy
  5. 5.Market Insights
    1. 5.1Consumer Insights & End-User Perspective
    2. 5.2Consumer Experience Benchmarking
    3. 5.3Opportunity Mapping
    4. 5.4Distribution Channel Analysis
    5. 5.5Pricing Trend Analysis
    6. 5.6Regulatory Compliance & Standards Framework
    7. 5.7ESG & Sustainability Analysis
    8. 5.8Disruption & Risk Scenarios
    9. 5.9Return on Investment & Cost-Benefit Analysis
  6. 6.Cumulative Impact of Artificial Intelligence 2026
  7. 7.Resuscitation Devices Market, by Product Type
    1. 7.1Introduction
    2. 7.2Airway Management Devices
      1. 7.2.1Ventilators
      2. 7.2.2Laryngeal Mask Airways
      3. 7.2.3Endotracheal Tubes
      4. 7.2.4Resuscitators
    3. 7.3Defibrillators
      1. 7.3.1Automated External Defibrillators
      2. 7.3.2Manual Defibrillators
    4. 7.4Oxygen Delivery Equipment
    5. 7.5Suction Devices
  8. 8.Resuscitation Devices Market, by Patient Type
    1. 8.1Introduction
    2. 8.2Adult
    3. 8.3Pediatric
    4. 8.4Neonatal
  9. 9.Resuscitation Devices Market, by Portability
    1. 9.1Introduction
    2. 9.2Portable
    3. 9.3Stationary
    4. 9.4Wearable
  10. 10.Resuscitation Devices Market, by Application
    1. 10.1Introduction
    2. 10.2Cardiac Arrest
      1. 10.2.1Cardiac Pacing
      2. 10.2.2Cardioversion
      3. 10.2.3Defibrillation
    3. 10.3Respiratory Failure
    4. 10.4Trauma Care
    5. 10.5Neonatal Resuscitation
  11. 11.Resuscitation Devices Market, by End User
    1. 11.1Introduction
    2. 11.2Ambulatory Care Centers
    3. 11.3Emergency Medical Services
    4. 11.4Homecare
    5. 11.5Hospitals
    6. 11.6Specialty Clinics
  12. 12.Resuscitation Devices Market, by Sales Channel
    1. 12.1Introduction
    2. 12.2Offline
    3. 12.3Online
  13. 13.Resuscitation Devices Market, by Region
    1. 13.1Introduction
    2. 13.2Asia-Pacific
    3. 13.3North America
    4. 13.4Latin America
    5. 13.5Europe
    6. 13.6Middle East
    7. 13.7Africa
  14. 14.Resuscitation Devices Market, by Group
    1. 14.1Introduction
    2. 14.2ASEAN
    3. 14.3GCC
    4. 14.4European Union
    5. 14.5BRICS
    6. 14.6G7
    7. 14.7NATO
  15. 15.Resuscitation Devices Market, by Country
    1. 15.1Introduction
    2. 15.2United States
    3. 15.3Canada
    4. 15.4Mexico
    5. 15.5Brazil
    6. 15.6United Kingdom
    7. 15.7Germany
    8. 15.8France
    9. 15.9Russia
    10. 15.10Italy
    11. 15.11Spain
    12. 15.12China
    13. 15.13India
    14. 15.14Japan
    15. 15.15Australia
    16. 15.16South Korea
  16. 16.Competitive Landscape
    1. 16.1Market Share Analysis, 2025
    2. 16.2Market Concentration Analysis, 2025
      1. 16.2.1Concentration Ratio (CR)
      2. 16.2.2Herfindahl Hirschman Index (HHI)
    3. 16.3Recent Developments & Impact Analysis, 2025
    4. 16.4Product Portfolio Analysis, 2025
    5. 16.5Benchmarking Analysis, 2025
  17. 17.Company Profiles
    1. 17.1Ambu A/S
    2. 17.2Asahi Kasei Corporation
    3. 17.3Becton, Dickinson and Company
    4. 17.4BPL Medical Technologies Private Limited
    5. 17.5Bunnell, Inc.
    6. 17.6Cardinal Health, Inc.
    7. 17.7Drägerwerk AG & Co. KGaA
    8. 17.8Flexicare Medical Limited
    9. 17.9GE HealthCare Technologies Inc.
    10. 17.10Getinge AB
    11. 17.11Hamilton Medical AG
    12. 17.12Intersurgical Ltd.
    13. 17.13Koninklijke Philips N.V.
    14. 17.14Masimo Corporation
    15. 17.15Medtronic plc
    16. 17.16Mercury Medical, LLC
    17. 17.17Nihon Kohden Corporation
    18. 17.18Penlon Limited
    19. 17.19ResMed Inc.
    20. 17.20SCHILLER AG
    21. 17.21Shenzhen Comen Medical Instruments Co., Ltd.
    22. 17.22Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
    23. 17.23Smiths Group plc
    24. 17.24Stryker Corporation
    25. 17.25Teleflex Incorporated
    26. 17.26VBM Medizintechnik GmbH
  18. 18.Key Experts

Loading the sample request form…